Abstract
Gaucher disease type 2 [OMIM #230800] is a rare lysosomal storage disorder with usual onset between 3 and 6 months of age leading to progressive neurodegeneration and death within the first 2 years of life. Rarely it may lack the characteristic symptom-free period and initially manifest prenatally or in the neonatal period. The early course of neonatal onset classic type 2 variants is not well known, and reports of early histological changes in the liver of type 2 Gaucher disease patients are scarce. We describe a patient who presented in the immediate postnatal period with cholestasis without hepatomegaly associated with hepatocellular giant-cell transformation on liver biopsy, thrombocytopenia, and failure to thrive. This was initially thought to represent neonatal giant-cell hepatitis and the correct diagnosis was not made until the age of 6 months. Hepatocellular giant transformation has not been described in the classic acute neuronopathic form of GD. However, it has been reported in congenital GD with nonimmune hydrops and neonatal hepatitis, an example of perinatal lethal Gaucher disease (PLGD), which sometimes is regarded as an entity separate from GD type 2. Our case illustrates that neonatal cholestasis may be part of a spectrum of manifestations which spans a continuum between the PLGD and classic type 2 GD. Giant cells are a nonspecific finding but may reflect the presence of a systemic inflammatory process that recently has been implicated in the brain stem degeneration associated with acute neuronopathic GD.
Competing interests: None declared.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abrahamov A, Elstein D, Gross-Tsur V, Farber B, Glaser Y, Hadas-Halpern I et al (1995) Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet 346:1000–1003
Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM (1997) Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. QJM 90:19–25
Barbier C, Devisme L, Dobbelaere D, Noizet O, Nelken B, Gottrand F (2002) Neonatal cholestasis and infantile Gaucher disease: a case report. Acta Paediatr 91:1399–1401
Ben Turkia H, Tebib N, Azzouz H, Abdelmoula MS, Ben Chehida A, Caillaud C et al (2009) Phenotypic continuum of type 2 Gaucher's disease: an intermediate phenotype between perinatal-lethal and classic type 2 Gaucher's disease. J Perinatol 29:170–172
Cormand B, Harboe TL, Gort L, Campoy C, Blanco M, Chamoles N et al (1998) Mutation analysis of Gaucher disease patients from Argentina: high prevalence of the RecNciI mutation. Am J Med Genet 80:343–351
Cox TM (2001) Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis 24 (Suppl 2):106–121, discussion 187–108
Crawford JM (2006) Basic mechanisms in hepatopathology. In: Burt AD, Portmann BC, Ferrell LD (eds) MacSween's pathology of the liver, 5th edn. Churchill Livingstone Elsevier, Philadelphia
Gery I, Zigler JS Jr, Brady RO, Barranger JA (1981) Selective effects of glucocerebroside (Gaucher's storage material) on macrophage cultures. J Clin Invest 68:1182–1189
Grabowski GA, Beutler E (2006) Chapter 146: Gaucher disease. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE (eds) The online metabolic and molecular bases of inherited disease. McGraw-Hill, New York, Chapter 146
Hong YB, Kim EY, Jung SC (2006) Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse. J Korean Med Sci 21:733–738
Hruska KS, LaMarca ME, Scott CR, Sidransky E (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29:567–583
Jevon GP, Dimmick JE (1998) Histopathologic approach to metabolic liver disease: Part 1. Pediatr Dev Pathol 1:179–199
Michelakakis H, Spanou C, Kondyli A, Dimitriou E, Van Weely S, Hollak CE et al (1996) Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease. Biochim Biophys Acta 1317:219–222
Mignot C, Gelot A, Bessieres B, Daffos F, Voyer M, Menez F et al (2003) Perinatal-lethal Gaucher disease. Am J Med Genet A 120A:338–344
Mignot C, Doummar D, Maire I, De Villemeur TB (2006) Type 2 Gaucher disease: 15 new cases and review of the literature. Brain Dev 28:39–48
Orvisky E, Park JK, LaMarca ME, Ginns EI, Martin BM, Tayebi N et al (2002) Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol Genet Metab 76:262–270
Roth P, Sklower Brooks S, Potaznik D, Cooma R, Sahdev S (2005) Neonatal Gaucher disease presenting as persistent thrombocytopenia. J Perinatol 25:356–358
Schwartz IV, Krug B, Picon PD (2009) Commentaire de l'article "Cholestase neonatale revelatrice d'un phenotype intermediaire d'une maladie de Gaucher type 2". Arch Pediatr 16:1190–1191
Sidransky E (1997) New perspectives in type 2 Gaucher disease. Adv Pediatr 44:73–107
Sidransky E (2004) Gaucher disease: complexity in a "simple" disorder. Mol Genet Metab 83:6–15
Spear GS, Beutler E, Hungs M (2007) Congenital Gaucher disease with nonimmune hydrops/erythroblastosis, infantile arterial calcification, and neonatal hepatitis/fibrosis. Clinicopathologic report with enzymatic and genetic analysis. Fetal Pediatr Pathol 26:153–168
Tayebi N, Stubblefield BK, Park JK, Orvisky E, Walker JM, LaMarca ME et al (2003) Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease. Am J Hum Genet 72:519–534
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Maurizio Scarpa.
Rights and permissions
Copyright information
© 2011 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Elias, A.F., Johnson, M.R., Boitnott, J.K., Valle, D. (2011). Neonatal Cholestasis as Initial Manifestation of Type 2 Gaucher Disease: A Continuum in the Spectrum of Early Onset Gaucher Disease. In: JIMD Reports - Case and Research Reports, 2012/2. JIMD Reports, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2011_104
Download citation
DOI: https://doi.org/10.1007/8904_2011_104
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28095-5
Online ISBN: 978-3-642-28096-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)